American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Procter & Gamble
PG
|
+$258M |
| 2 |
Texas Instruments
TXN
|
+$193M |
| 3 |
American Tower
AMT
|
+$183M |
| 4 |
3M
MMM
|
+$163M |
| 5 |
Schlumberger
SLB
|
+$153M |
Top Sells
| 1 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$559M |
| 2 |
PepsiCo
PEP
|
+$356M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$317M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$316M |
| 5 |
Apple
AAPL
|
+$312M |
Sector Composition
| 1 | Financials | 15.32% |
| 2 | Healthcare | 13.4% |
| 3 | Technology | 12.61% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFII
1026
DELISTED
Electronics for Imaging
EFII
| $2.15M | ﹤0.01% |
+44,073
| New | +$2.15M |
|
|
AERI
1027
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.14M | ﹤0.01% |
47,119
-195
| -0.4% | -$8.84K |
|
1028
Texas Roadhouse
TXRH
$11.1B
| $2.12M | ﹤0.01% |
47,696
-61,368
| -56% | -$2.73M |
|
|
VAR
1029
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.11M | ﹤0.01% |
23,102
-3,243
| -12% | -$295K |
|
|
EXTN
1030
DELISTED
Exterran Corporation
EXTN
| $2.09M | ﹤0.01% |
+66,522
| New | +$2.09M |
|
1031
Light & Wonder
LNW
$7.48B
| $2.09M | ﹤0.01% |
88,270
+8,623
| +11% | +$204K |
|
1032
Mativ Holdings
MATV
$674M
| $2.07M | ﹤0.01% |
49,871
-66,663
| -57% | -$2.76M |
|
1033
United Therapeutics
UTHR
$18.3B
| $2.06M | ﹤0.01% |
15,212
-441
| -3% | -$59.7K |
|
|
CRCM
1034
DELISTED
CARE.COM, INC.
CRCM
| $2.05M | ﹤0.01% |
164,085
+74,297
| +83% | +$930K |
|
|
PTLA
1035
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.03M | ﹤0.01% |
51,833
+19,460
| +60% | +$763K |
|
1036
Forestar Group
FOR
$1.41B
| $2.02M | ﹤0.01% |
148,116
+101,640
| +219% | +$1.39M |
|
|
PF
1037
DELISTED
Pinnacle Foods, Inc.
PF
| $2.02M | ﹤0.01% |
34,870
-1,839
| -5% | -$106K |
|
|
JNS
1038
DELISTED
Janus Capital Group Inc
JNS
| $2.02M | ﹤0.01% |
152,718
| – | – |
|
1039
iShares MSCI Taiwan ETF
EWT
$6.52B
| $1.98M | ﹤0.01% |
59,543
-17,592
| -23% | -$585K |
|
1040
H.B. Fuller
FUL
$3.33B
| $1.97M | ﹤0.01% |
38,237
-96,543
| -72% | -$4.98M |
|
1041
Travere Therapeutics
TVTX
$2.09B
| $1.97M | ﹤0.01% |
106,701
-53,781
| -34% | -$993K |
|
1042
Stride
LRN
$6.91B
| $1.97M | ﹤0.01% |
102,638
+57,748
| +129% | +$1.11M |
|
|
RDUS
1043
DELISTED
Radius Health, Inc.
RDUS
| $1.97M | ﹤0.01% |
50,858
+5,587
| +12% | +$216K |
|
1044
EPR Properties
EPR
$4.45B
| $1.91M | ﹤0.01% |
25,898
-379
| -1% | -$27.9K |
|
|
SAGE
1045
DELISTED
Sage Therapeutics
SAGE
| $1.9M | ﹤0.01% |
26,771
-148
| -0.5% | -$10.5K |
|
1046
Hasbro
HAS
$11B
| $1.89M | ﹤0.01% |
18,888
-544,453
| -97% | -$54.3M |
|
1047
Northwest Bancshares
NWBI
$1.83B
| $1.88M | ﹤0.01% |
111,663
-18,793
| -14% | -$316K |
|
1048
Ironwood Pharmaceuticals
IRWD
$213M
| $1.88M | ﹤0.01% |
+131,502
| New | +$1.88M |
|
|
BWLD
1049
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $1.87M | ﹤0.01% |
12,260
+1,219
| +11% | +$186K |
|
1050
Leidos
LDOS
$23.6B
| $1.87M | ﹤0.01% |
36,584
-3,411
| -9% | -$174K |
|